+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopsy Guidance System Market Research Report by Product, by Application, by End-use, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5454872
  • Report
  • January 2022
  • Region: Global
  • 190 Pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2022

FEATURED COMPANIES

  • ARGON MEDICAL
  • C. R. Bard, Inc.
  • Cook Medical
  • Hologic, Inc.
  • Medtronic PLC
  • PLANMED OY
The Global Biopsy Guidance System Market size was estimated at USD 934.54 million in 2020, is expected to reach USD 988.93 million in 2021, and is projected to grow at a CAGR of 6.18% to reach USD 1,422.55 million by 2027.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biopsy Guidance System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across MRI Guided Biopsy, Stereotactic Guided Biopsy, and Ultrasound Guided Biopsy.
  • Based on Application, the market was studied across Brain Biopsy and Breast Biopsy.
  • Based on End-use, the market was studied across Diagnostic Centers, Hospitals, Research and Academic Institutes, and Specialty Clinics.
  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopsy Guidance System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopsy Guidance System Market, including ARGON MEDICAL, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Fujifilm Holdings Corporation, Gallini Medical, Hologic, Inc., INRAD Inc., Medtronic PLC, Olympus Corporation, PLANMED OY, and Siemens Healthineers.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biopsy Guidance System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopsy Guidance System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopsy Guidance System Market?
4. What is the competitive strategic window for opportunities in the Global Biopsy Guidance System Market?
5. What are the technology trends and regulatory frameworks in the Global Biopsy Guidance System Market?
6. What is the market share of the leading vendors in the Global Biopsy Guidance System Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopsy Guidance System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ARGON MEDICAL
  • C. R. Bard, Inc.
  • Cook Medical
  • Hologic, Inc.
  • Medtronic PLC
  • PLANMED OY
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cancer
5.1.1.2. Rising preference for minimally invasive biopsy treatments
5.1.1.3. Increasing government and non-government initiatives related to the biopsy guidance
5.1.2. Restraints
5.1.2.1. High cost associated with biopsy guidance system
5.1.3. Opportunities
5.1.3.1. Continuous technological advancements such as robot-assisted biopsy guidance systems, needle-based biopsy guns
5.1.3.2. Rising awareness of breast cancer treatment and diagnosis
5.1.4. Challenges
5.1.4.1. Complications associated with imaging systems
5.2. Cumulative Impact of COVID-19

6. Biopsy Guidance System Market, by Product
6.1. Introduction
6.2. MRI Guided Biopsy
6.3. Stereotactic Guided Biopsy
6.4. Ultrasound Guided Biopsy

7. Biopsy Guidance System Market, by Application
7.1. Introduction
7.2. Brain Biopsy
7.3. Breast Biopsy

8. Biopsy Guidance System Market, by End-use
8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research and Academic Institutes
8.5. Specialty Clinics

9. Americas Biopsy Guidance System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biopsy Guidance System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Biopsy Guidance System Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. ARGON MEDICAL
13.2. B. Braun Melsungen AG
13.3. Becton, Dickinson and Company
13.4. Boston Scientific Corporation
13.5. C. R. Bard, Inc.
13.6. Cardinal Health, Inc.
13.7. Cook Medical
13.8. Fujifilm Holdings Corporation
13.9. Gallini Medical
13.10. Hologic, Inc.
13.11. INRAD Inc.
13.12. Medtronic PLC
13.13. Olympus Corporation
13.14. PLANMED OY
13.15. Siemens Healthineers

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
Figure 1. Global Biopsy Guidance System Market: Research Process
Figure 2. Global Biopsy Guidance System Market: Market Dynamics
Figure 3. Global Biopsy Guidance System Market Size, by Product, 2020 Vs 2027 (%)
Figure 4. Global Biopsy Guidance System Market Size, by Product, 2020 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Biopsy Guidance System Market Size, by Product, 2027
Figure 6. Global Biopsy Guidance System Market Size, by Mri Guided Biopsy, 2018-2027 (USD Million)
Figure 7. Global Biopsy Guidance System Market Size, by Mri Guided Biopsy, by Region, 2020 Vs 2027 (USD Million)
Figure 8. Global Biopsy Guidance System Market Size, by Stereotactic Guided Biopsy, 2018-2027 (USD Million)
Figure 9. Global Biopsy Guidance System Market Size, by Stereotactic Guided Biopsy, by Region, 2020 Vs 2027 (USD Million)
Figure 10. Global Biopsy Guidance System Market Size, by Ultrasound Guided Biopsy, 2018-2027 (USD Million)
Figure 11. Global Biopsy Guidance System Market Size, by Ultrasound Guided Biopsy, by Region, 2020 Vs 2027 (USD Million)
Figure 12. Global Biopsy Guidance System Market Size, by Application, 2020 Vs 2027 (%)
Figure 13. Global Biopsy Guidance System Market Size, by Application, 2020 Vs 2027 (USD Million)
Figure 14. Competitive Strategic Window For Global Biopsy Guidance System Market Size, by Application, 2027
Figure 15. Global Biopsy Guidance System Market Size, by Brain Biopsy, 2018-2027 (USD Million)
Figure 16. Global Biopsy Guidance System Market Size, by Brain Biopsy, by Region, 2020 Vs 2027 (USD Million)
Figure 17. Global Biopsy Guidance System Market Size, by Breast Biopsy, 2018-2027 (USD Million)
Figure 18. Global Biopsy Guidance System Market Size, by Breast Biopsy, by Region, 2020 Vs 2027 (USD Million)
Figure 19. Global Biopsy Guidance System Market Size, by End-Use, 2020 Vs 2027 (%)
Figure 20. Global Biopsy Guidance System Market Size, by End-Use, 2020 Vs 2027 (USD Million)
Figure 21. Competitive Strategic Window For Global Biopsy Guidance System Market Size, by End-Use, 2027
Figure 22. Global Biopsy Guidance System Market Size, by Diagnostic Centers, 2018-2027 (USD Million)
Figure 23. Global Biopsy Guidance System Market Size, by Diagnostic Centers, by Region, 2020 Vs 2027 (USD Million)
Figure 24. Global Biopsy Guidance System Market Size, by Hospitals, 2018-2027 (USD Million)
Figure 25. Global Biopsy Guidance System Market Size, by Hospitals, by Region, 2020 Vs 2027 (USD Million)
Figure 26. Global Biopsy Guidance System Market Size, by Research And Academic Institutes, 2018-2027 (USD Million)
Figure 27. Global Biopsy Guidance System Market Size, by Research And Academic Institutes, by Region, 2020 Vs 2027 (USD Million)
Figure 28. Global Biopsy Guidance System Market Size, by Specialty Clinics, 2018-2027 (USD Million)
Figure 29. Global Biopsy Guidance System Market Size, by Specialty Clinics, by Region, 2020 Vs 2027 (USD Million)
Figure 30. Americas Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 31. Argentina Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 32. Brazil Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 33. Canada Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 34. Mexico Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 35. United States Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 36. Asia-Pacific Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 37. Australia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 38. China Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 39. India Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 40. Indonesia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 41. Japan Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 42. Malaysia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 43. Philippines Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 44. Singapore Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 45. South Korea Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 46. Taiwan Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 47. Thailand Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 48. Europe, Middle East & Africa Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 49. France Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 50. Germany Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 51. Italy Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 52. Netherlands Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 53. Qatar Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 54. Russia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 55. Saudi Arabia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 56. South Africa Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 57. Spain Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 58. United Arab Emirates Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 59. United Kingdom Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Figure 60. Global Biopsy Guidance System Market: Fpnv Positioning Matrix
Figure 61. Global Biopsy Guidance System Market: Share, by Key Player, 2020
Figure 62. Competitive Scenario Analysis In Global Biopsy Guidance System Market, by Type

List of Tables
Table 1. Global Biopsy Guidance System Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Biopsy Guidance System Market Size, by Product, 2018-2027 (USD Million)
Table 4. Global Biopsy Guidance System Market Size, by Mri Guided Biopsy, by Region, 2018-2027 (USD Million)
Table 5. Global Biopsy Guidance System Market Size, by Stereotactic Guided Biopsy, by Region, 2018-2027 (USD Million)
Table 6. Global Biopsy Guidance System Market Size, by Ultrasound Guided Biopsy, by Region, 2018-2027 (USD Million)
Table 7. Global Biopsy Guidance System Market Size, by Application, 2018-2027 (USD Million)
Table 8. Global Biopsy Guidance System Market Size, by Brain Biopsy, by Region, 2018-2027 (USD Million)
Table 9. Global Biopsy Guidance System Market Size, by Breast Biopsy, by Region, 2018-2027 (USD Million)
Table 10. Global Biopsy Guidance System Market Size, by End-Use, 2018-2027 (USD Million)
Table 11. Global Biopsy Guidance System Market Size, by Diagnostic Centers, by Region, 2018-2027 (USD Million)
Table 12. Global Biopsy Guidance System Market Size, by Hospitals, by Region, 2018-2027 (USD Million)
Table 13. Global Biopsy Guidance System Market Size, by Research And Academic Institutes, by Region, 2018-2027 (USD Million)
Table 14. Global Biopsy Guidance System Market Size, by Specialty Clinics, by Region, 2018-2027 (USD Million)
Table 15. Americas Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 16. Argentina Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 17. Brazil Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 18. Canada Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 19. Mexico Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 20. United States Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 21. Asia-Pacific Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 22. Australia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 23. China Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 24. India Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 25. Indonesia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 26. Japan Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 27. Malaysia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 28. Philippines Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 29. Singapore Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 30. South Korea Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 31. Taiwan Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 32. Thailand Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 33. Europe, Middle East & Africa Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 34. France Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 35. Germany Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 36. Italy Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 37. Netherlands Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 38. Qatar Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 39. Russia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 40. Saudi Arabia Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 41. South Africa Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 42. Spain Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 43. United Arab Emirates Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 44. United Kingdom Biopsy Guidance System Market Size, 2018-2027 (USD Million)
Table 45. Global Biopsy Guidance System Market: Scores
Table 46. Global Biopsy Guidance System Market: Business Strategy
Table 47. Global Biopsy Guidance System Market: Product Satisfaction
Table 48. Global Biopsy Guidance System Market: Ranking
Table 49. Global Biopsy Guidance System Market: Share, by Key Player, 2020
Table 50. Global Biopsy Guidance System Market: Merger & Acquisition
Table 51. Global Biopsy Guidance System Market: Agreement, Collaboration, & Partnership
Table 52. Global Biopsy Guidance System Market: New Product Launch & Enhancement
Table 53. Global Biopsy Guidance System Market: Investment & Funding
Table 54. Global Biopsy Guidance System Market: Award, Recognition, & Expansion
Table 55. Global Biopsy Guidance System Market: License & Pricing
Note: Product cover images may vary from those shown
  • ARGON MEDICAL
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Cook Medical
  • Fujifilm Holdings Corporation
  • Gallini Medical
  • Hologic, Inc.
  • INRAD Inc.
  • Medtronic PLC
  • Olympus Corporation
  • PLANMED OY
  • Siemens Healthineers
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll